In the news release, New Wave: Welcomes Iman Nevab, Homeopathic Research Expert to the Scientific Advisory Board, issued 21-Jan-2021 by New Wave Holdings Corp. over
CNW, we are advised by the company that the headline should read “Iman Navab” rather than “Iman Nevab.” Also, in the About the Company section, the OTC ticker should be ”TRMNF” instead of ”TRMND”
as originally issued inadvertently. The complete, corrected release follows:
New Wave: Welcomes Iman Navab, Homeopathic Research Expert to the Scientific Advisory Board
TORONTO, Jan. 21, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an
investment issuer that provides capital and support services, announced its latest addition to the scientific advisory board.
New Wave Holdings Announces New Scientific Advisory Board Member
New Wave Holdings Corp. announced today the appointment of a new member to their scientific advisory board. Iman Navab will be joining Dennis
McKenna and Dr. Richard Knowles on New Wave’s expert advisory board – providing innovative guidance and insight to support the company’s continued growth and
development in the blooming psychedelic and functioning mushroom sector.
Mr. Navab is a registered healthcare provider and brings years of experience to the table as a homeopathic practitioner, researcher, botanist, and historian of homeopathy. He is the president of
the Applied Research in Homeopathy Foundation of Canada and has authored two books – Miasma of Cancer and An Interview with Samuel
Hahnemann.
With his extensive knowledge in homeopathy and six years of academic studies in natural medicine at a prominent Canadian college under his belt, Mr. Navab will utilize his skills and expertise to
leverage New Wave Holdings’ strategic positioning in the industry.
“It is with great pleasure that we are formally introducing our newest member to the advisory team,” said Daniel Fox, CEO of New Wave Holdings Corp. “Mr. Navab has a
wealth of experience in homeopathy and alternative medicine, and his expertise and insights will be invaluable to our company’s continuing endeavors in the psychedelic sector. We look forward to
exponential growth and progress in the upcoming years with the help of our impressive panel of experts in the field.”
In addition to his expertise in natural medicine, he is also the founder of Dynamise, a company that focuses on the development and creation of natural skincare and health products that are backed
by science and research.
“It is an honour to be a member of New Wave’s scientific advisory board. I strongly believe that science of mycology and herbology has great medicinal benefits for the wellbeing of mankind,
which must be explored diligently. As Albert Einstein said – Look deep into nature, and then you will understand everything better.” Said Mr. Navab.
ABOUT NEW WAVE HOLDINGS CORP.
New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC: TRMNF) is an investment issuer focused on rapid growth in the Nutraceutical space, with an impressive and growing number of organic plant-based
health care products. New Wave is also focusing on the burgeoning psychedelic sector and support for adaptive and progressive mental health products and therapies. In the psychedelic sector, New Wave
will focus on supporting research on active psychedelic compounds, focused on the creation of consumer products New Wave also contains various health and beauty products within its portfolio of
non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.
Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com.
The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that
term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
FORWARD-LOOKING INFORMATION DISCLAIMER
Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the
closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not
always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward–looking information involves known and
unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company’s actual results
could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations
in international markets, transaction execution risk, changes to the Company’s strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes
that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these
expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the
Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether
as a result of new information, future events or otherwise, except as required by applicable securities legislation.